Covered recipient · General Payments record
MICHAEL BISHOP
Allopathic & Osteopathic Physicians Pediatrics
General Payments · PY2018–2024
$2,794.80
- Reported across 117 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $509.53 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| SANOFI-AVENTIS U.S. LLC | $187.54 | 4 |
| UCB, Inc. | $138.15 | 3 |
| Corium, Inc. | $104.03 | 5 |
| AYTU BioPharma, Inc. | $17.46 | 1 |
| IRONSHORE PHARMACEUTICALS INC. | $16.47 | 1 |
| Neos Therapeutics, LP | $16.04 | 1 |
| Cranial Technologies, Inc | $15.37 | 1 |
| Tris Pharma Inc | $14.47 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Aytu BioPharma, Inc. | $17.46 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1082661451 | CMS |
| Corium, LLC | $17.98 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100104082 | CMS |
| Corium, LLC | $12.73 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100159809 | CMS |
| Corium, LLC | $20.91 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100180274 | CMS |
| Corium, LLC | $24.41 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100217675 | CMS |
| Corium, LLC | $28.00 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100217897 | CMS |
| Cranial Technologies, Inc | $15.37 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1082228584 | CMS |
| IRONSHORE PHARMACEUTICALS INC. | $16.47 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146260307 | CMS |
| Neos Therapeutics, LP | $16.04 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1082664649 | CMS |
| SANOFI-AVENTIS U.S. LLC | $20.80 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139873011 | CMS |
| SANOFI-AVENTIS U.S. LLC | $121.86 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139873037 | CMS |
| SANOFI-AVENTIS U.S. LLC | $20.80 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139873039 | CMS |
| SANOFI-AVENTIS U.S. LLC | $24.08 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139873099 | CMS |
| Tris Pharma Inc | $14.47 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147219114 | CMS |
| UCB, Inc. | $44.87 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143374958 | CMS |
| UCB, Inc. | $48.54 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143091642 | CMS |
| UCB, Inc. | $44.74 | 11/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143091644 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.